{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:37:22Z","timestamp":1753882642778,"version":"3.41.2"},"reference-count":50,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100004794","name":"centre national de la recherche scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> Benign prostatic hyperplasia (BPH), a common urological disease in aging men, frequently produces lower urinary tract symptoms (LUTS). Clinical studies have shown that terazosin relaxes the smooth muscle of the prostate and bladder, facilitates bladder emptying, improves LUTS, increases maximum urinary flow, and reduces the residual volume of urine. D-004, a lipid extract of the fruit of the Cuban royal palm ( Roystonea regia), presents a similar efficacy to Saw palmetto. Clinical studies have demonstrated its efficacy and safety in short- and medium-term trials in patients with BPH. The objective of this study was to compare the efficacy and tolerability of D-004 with terazosin for 6\u2009months on LUTS in patients with BPH. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> The present phase\u2009III study had an open, randomized, comparative design, with two parallel groups who received D-004 (320\u2009mg\/day) or terazosin (5\u2009mg\/day) for 6\u2009months. The study included men at least 50\u2009years of age, with evidence of the LUTS of moderate intensity according to the International Symptoms of the Prostate (IPSS). The effects on the IPSS Scale was the primary efficacy variable. The effects on the size of the prostate and the residual volume were secondary variables. The subjective self-perception of symptom relief at trial completion was a collateral outcome. Analysis was done by intention-to-treat. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> The study included 100 men with a diagnosis of BPH, confirmed by digital rectal examination and ultrasonography, and moderate LUTS (IPSS score &gt;7, &lt;19). Baseline characteristics were similar in both groups. Nine patients did not continue the study: one from group D-004 (due to protocol violation) and eight from the terazosin group (six due to adverse events and two due to protocol violation; p\u2009&lt;\u20090.01). D-004 and terazosin significantly reduced the IPSS scores at the end of the 6\u2009months of therapy by 74.2% and 66.1%, respectively, with respect to baseline values. Comparisons between groups performed showed that, at the end of the treatment, D-004 was more effective ( p\u2009&lt;\u20090.05) than terazosin in reducing the IPSS score. Although the average size of the prostate was reduced in both groups, this reduction reached statistical significance only for D-004. On the other hand, postvoid residual volume was significantly and similarly reduced in both groups. Both treatments were safe, while D-004 was better tolerated than terazosin. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p> D-004 administered at a dose of 320\u2009mg\/day for 6\u2009months showed comparable efficacy with terazosin (5\u2009mg\/day) in reducing the LUTS (IPSS score), producing a significant decrease in prostate volume and postvoid residual volume. Both treatments were safe, with better tolerability for D-004 as compared with terazosin. <\/jats:p><\/jats:sec>","DOI":"10.1177\/1756287219854923","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T12:25:04Z","timestamp":1560255904000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and tolerability of <i>Roystonea regia<\/i> lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study"],"prefix":"10.1177","volume":"11","author":[{"given":"Ra\u00fal","family":"Guzm\u00e1n","sequence":"first","affiliation":[{"name":"Salvador Allende Hospital, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-4129","authenticated-orcid":false,"given":"Julio C.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"National Center for Scientific Research, 25 Avenue and 158 st, Cubanacan, Playa, Havana, 113000, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Pedroso","sequence":"additional","affiliation":[{"name":"Salvador Allende Hospital, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"National Center for Scientific Research, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Illnait","sequence":"additional","affiliation":[{"name":"National Center for Scientific Research, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah\u00ed","family":"Mendoza","sequence":"additional","affiliation":[{"name":"National Center for Scientific Research, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana T.","family":"Quiala","sequence":"additional","affiliation":[{"name":"Salvador Allende Hospital, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunilda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Salvador Allende Hospital, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilma","family":"Mena","sequence":"additional","affiliation":[{"name":"Salvador Allende Hospital, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylim","family":"Rod\u00edguez","sequence":"additional","affiliation":[{"name":"Medical Surgical Research Center, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marbelis","family":"Campos","sequence":"additional","affiliation":[{"name":"Medical Surgical Research Center, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"National Clinical Trials Coordinator Center, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanet","family":"Alvarez","sequence":"additional","affiliation":[{"name":"National Clinical Trials Coordinator Center, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"National Clinical Trials Coordinator Center, Havana, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"bibr1-1756287219854923","first-page":"36","volume":"41","author":"Yunou WU","year":"2016","journal-title":"US Pharm"},{"key":"bibr2-1756287219854923","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2011.tb03185.x"},{"key":"bibr3-1756287219854923","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4888"},{"key":"bibr4-1756287219854923","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2018.045"},{"key":"bibr5-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-063014-123902"},{"key":"bibr6-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107593"},{"key":"bibr7-1756287219854923","doi-asserted-by":"publisher","DOI":"10.2174\/092986711796642517"},{"key":"bibr8-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-6867(11)60015-8"},{"key":"bibr9-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0b013e32834d9bfd"},{"key":"bibr10-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107593"},{"key":"bibr11-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.05.033"},{"key":"bibr12-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02157.x"},{"key":"bibr13-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01344-9"},{"key":"bibr14-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.01.023"},{"key":"bibr15-1756287219854923","doi-asserted-by":"publisher","DOI":"10.18565\/urology.2018.2.114-120"},{"key":"bibr16-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11172.x"},{"key":"bibr17-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.08.257"},{"key":"bibr18-1756287219854923","first-page":"41","volume":"27","author":"Arruzazabala ML","year":"2008","journal-title":"Latin Am J Pharm"},{"key":"bibr19-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2005.01.001"},{"key":"bibr20-1756287219854923","first-page":"193","volume":"31","author":"Carbajal D","year":"2005","journal-title":"Drugs Exp Clin Res"},{"key":"bibr21-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2006.12.004"},{"key":"bibr22-1756287219854923","first-page":"6","volume":"38","author":"P\u00e9rez Y","year":"2007","journal-title":"Rev CENIC Cien Biol"},{"key":"bibr23-1756287219854923","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200506050-00004"},{"key":"bibr24-1756287219854923","first-page":"213","volume":"25","author":"Men\u00e9ndez R","year":"2006","journal-title":"Acta Farm Bonaerense"},{"key":"bibr25-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7262.2008.00385.x"},{"key":"bibr26-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2008.34"},{"key":"bibr27-1756287219854923","first-page":"1","volume":"3","author":"Guzm\u00e1n R","year":"2013","journal-title":"IOSR PHR"},{"key":"bibr28-1756287219854923","first-page":"710","volume":"27","author":"Guti\u00e9rrez A","year":"2008","journal-title":"Lat Am J Pharm"},{"key":"bibr29-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2008.01.002"},{"key":"bibr30-1756287219854923","first-page":"12","volume":"38","author":"Carbajal D","year":"2007","journal-title":"Rev CENIC Cien Biol"},{"key":"bibr31-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1080\/01480540701873152"},{"key":"bibr32-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2011.07.061"},{"key":"bibr33-1756287219854923","first-page":"1","volume":"36","author":"Gutierrez A","year":"2005","journal-title":"Rev CNIC Cien Biol Ed especial (CD)"},{"key":"bibr34-1756287219854923","first-page":"36","author":"G\u00e1mez R","year":"2005","journal-title":"Rev CNIC Cien Biol Ed especial (CD)"},{"key":"bibr35-1756287219854923","volume":"1","author":"Gutierrez A","year":"2012","journal-title":"Rev Cub Toxicol"},{"key":"bibr36-1756287219854923","first-page":"254","volume":"32","author":"Gutierrez A","year":"2013","journal-title":"Rev Cub Inv Biom"},{"key":"bibr37-1756287219854923","first-page":"33","volume":"7","author":"L\u00f3pez E","year":"2008","journal-title":"Rev CNIC Cien Biol"},{"key":"bibr38-1756287219854923","first-page":"7","volume":"3","author":"Guzm\u00e1n R","year":"2013","journal-title":"IOSR PHR"},{"key":"bibr39-1756287219854923","first-page":"413","volume":"175","author":"Guzm\u00e1n R","year":"2016","journal-title":"Gazzetta Medica Italiana Archives per le Scienze Mediche"},{"journal-title":"Declaration of Helsinki- Ethical Principles for Medical research Involving Human Subjects","author":"World Medical Association","key":"bibr40-1756287219854923"},{"key":"bibr41-1756287219854923","unstructured":"Requerimientos para la notificacion y el reporte de eventos adversos graves e inesperados en los ensayos cl\u00ednicos. Regulaci\u00f3n No. 45-2007, Centro para el Control Estatal de los Medicamentos, Equipos y Dispositivos M\u00e9dicos (CECMED), MINSAP, La Habana, Cuba, 2007."},{"key":"bibr42-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31617-w"},{"key":"bibr43-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.01.094"},{"key":"bibr44-1756287219854923","unstructured":"National Clinical Guideline Centre. The management of lower urinary tract symptoms in men. NICE clinical guideline 2010. London: Royal College of Physicians; 2010. http:\/\/www.nice.org.uk\/nicemedia\/live\/12984\/48557\/48557.pdf (accessed 24 January 2019)."},{"key":"bibr45-1756287219854923","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.3058"},{"key":"bibr46-1756287219854923","first-page":"181","volume":"9","author":"Lepor H","year":"2007","journal-title":"Rev Urol"},{"key":"bibr47-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.01.033"},{"key":"bibr48-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.11.127"},{"key":"bibr49-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-4096.2001.02537.x-i1"},{"key":"bibr50-1756287219854923","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0b013e32834100b3"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287219854923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1756287219854923","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287219854923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:20:23Z","timestamp":1740968423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756287219854923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":50,"alternative-id":["10.1177\/1756287219854923"],"URL":"https:\/\/doi.org\/10.1177\/1756287219854923","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"type":"print","value":"1756-2872"},{"type":"electronic","value":"1756-2880"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"1756287219854923"}}